Skip to main content

OTCMKTS:NRXGQ - (NRXGQ) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
▲ +0.0028 (∞)
1 month | 3 months | 12 months
Get New (NRXGQ) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NRXGQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NRXGQ

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for (NRXGQ) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.00.

N/A

The current consensus among 0 investment analysts is to n/a stock in (NRXGQ). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/17/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/29/2017(FBRC)Reiterated RatingOutperform$17.50
i
(Data available from 5/10/2016 forward)
(NRXGQ) logo
NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.
Read More

Today's Range

Now: $0.00
$0.00
$0.00

50 Day Range

MA: N/A

52 Week Range

Now: $0.00
$0.00
$0.21

Volume

2,000 shs

Average Volume

26,223 shs

Market Capitalization

$36,260.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (NRXGQ)?

The following Wall Street analysts have issued stock ratings on (NRXGQ) in the last year:
View the latest analyst ratings for NRXGQ.

What is the current price target for (NRXGQ)?

0 Wall Street analysts have set twelve-month price targets for (NRXGQ) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for (NRXGQ) in the next year.
View the latest price targets for NRXGQ.

What is the current consensus analyst rating for (NRXGQ)?

(NRXGQ) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NRXGQ.

How do I contact (NRXGQ)'s investor relations team?

(NRXGQ)'s physical mailing address is PO Box 400, JAMISON, PA 18929-0400, United States. The healthcare company's listed phone number is +1-609-5538887. The official website for (NRXGQ) is www.nephrogenex.com.